Item 9 Current Valuation vs. Price To Sales
| INLB Stock | USD 0.0001 0.00 0.00% |
For Item 9 profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Item 9 to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Item 9 Labs utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Item 9's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Item 9 Labs over time as well as its relative position and ranking within its peers.
Item |
Item 9 Labs Price To Sales vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Item 9's current stock value. Our valuation model uses many indicators to compare Item 9 value to that of its competitors to determine the firm's financial worth. Item 9 Labs is considered the number one company in current valuation category among its peers. It also is currently regarded as number one stock in price to sales category among its peers . The ratio of Current Valuation to Price To Sales for Item 9 Labs is about 54,882,486 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Item 9 by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Item 9's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Item Current Valuation vs. Competition
Item 9 Labs is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 6.65 Trillion. Item 9 adds roughly 52.06 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Item Price To Sales vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Item 9 |
| = | 52.06 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Item 9 |
| = | 0.95 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Item Price To Sales Comparison
Item 9 is currently under evaluation in price to sales category among its peers.
Item 9 Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Item 9, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Item 9 will eventually generate negative long term returns. The profitability progress is the general direction of Item 9's change in net profit over the period of time. It can combine multiple indicators of Item 9, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.
Item Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Item 9. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Item 9 position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Item 9's important profitability drivers and their relationship over time.
Use Item 9 in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Item 9 position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Item 9 will appreciate offsetting losses from the drop in the long position's value.Item 9 Pair Trading
Item 9 Labs Pair Trading Analysis
The ability to find closely correlated positions to Item 9 could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Item 9 when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Item 9 - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Item 9 Labs to buy it.
The correlation of Item 9 is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Item 9 moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Item 9 Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Item 9 can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Item 9 position
In addition to having Item 9 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Item Pink Sheet
To fully project Item 9's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Item 9 Labs at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Item 9's income statement, its balance sheet, and the statement of cash flows.